Want to see AU:VBS full AI Analyst Report?
Total Valuation
Vectus Biosystems Limited has a market cap or net worth of AU$11.50M. The enterprise value is AU$3.87.
Market CapAU$11.50M
Enterprise ValueAU$3.87
Share Statistics
Vectus Biosystems Limited has 62,183,052 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding62,183,052
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Vectus Biosystems Limited’s return on equity (ROE) is 0.67 and return on invested capital (ROIC) is -47.75%.
Return on Equity (ROE)0.67
Return on Assets (ROA)0.41
Return on Invested Capital (ROIC)-47.75%
Return on Capital Employed (ROCE)-0.49
Revenue Per Employee0.00
Profits Per Employee311.73K
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Vectus Biosystems Limited is 6.4. Vectus Biosystems Limited’s PEG ratio is -0.02.
PE Ratio6.4
PS Ratio0.00
PB Ratio2.92
Price to Fair Value2.92
Price to FCF-11.82
Price to Operating Cash Flow-17.40
PEG Ratio-0.02
Income Statement
In the last 12 months, Vectus Biosystems Limited had revenue of 0.00 and earned 1.56M in profits. Earnings per share was 0.03.
Revenue0.00
Gross Profit-4.60K
Operating Income-1.37M
Pretax Income1.35M
Net Income1.56M
EBITDA-1.36M
Earnings Per Share (EPS)0.03
Cash Flow
In the last 12 months, operating cash flow was -573.39K and capital expenditures 5.00, giving a free cash flow of -573.39K billion.
Operating Cash Flow-573.39K
Free Cash Flow-573.39K
Free Cash Flow per Share>-0.01
Dividends & Yields
Vectus Biosystems Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.14
52-Week Price Change153.42%
50-Day Moving Average0.16
200-Day Moving Average0.14
Relative Strength Index (RSI)65.48
Average Volume (3m)6.52K
Important Dates
Vectus Biosystems Limited upcoming earnings date is Feb 19, 2027, TBA (Confirmed).
Last Earnings DateAug 30, 2026
Next Earnings DateFeb 19, 2027
Ex-Dividend Date―
Financial Position
Vectus Biosystems Limited as a current ratio of 3.78, with Debt / Equity ratio of 23.58%
Current Ratio3.78
Quick Ratio3.78
Debt to Market Cap0.08
Net Debt to EBITDA0.13
Interest Coverage Ratio-31.05
Taxes
In the past 12 months, Vectus Biosystems Limited has paid -209.55K in taxes.
Income Tax-209.55K
Effective Tax Rate-0.16
Enterprise Valuation
Vectus Biosystems Limited EV to EBITDA ratio is -4.84, with an EV/FCF ratio of -11.52.
EV to Sales0.00
EV to EBITDA-4.84
EV to Free Cash Flow-11.52
EV to Operating Cash Flow-11.52
Balance Sheet
Vectus Biosystems Limited has AU$3.52M in cash and marketable securities with AU$546.66K in debt, giving a net cash position of AU$2.97M billion.
Cash & Marketable SecuritiesAU$3.52M
Total DebtAU$546.66K
Net CashAU$2.97M
Net Cash Per ShareAU$0.05
Tangible Book Value Per ShareAU$0.04
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Vectus Biosystems Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―